Eyebot wants to make getting a prescription for glasses as fast as ordering a coffee.

REMAIN data show MCO-010 optogenetic therapy delivered durable ~3-line vision gains in retinitis pigmentosa regardless of ...

In previous articles, I introduced retinal reserve as a framework for understanding the retina’s ability to maintain function ...

Inflammasome Therapeutics' K8 slowed GA lesion growth 54% and showed a 4.0-letter vision advantage at six months in Phase 2. Phase 3 planned.

Grants of between EUR 65,000 and EUR 250,000 have been awarded to projects that cover intellectual, physical and vision ...

Results point to potential to restore vision with drugs, non-invasively, reversibly, via a mechanism that is independent to ...

Nasha Addarich Martínez Head of Editorial Initiatives and Data Journalism Nasha is the Head of Editorial Initiatives and Data Journalism at CNET. She leads the development and execution of proprietary ...

Virtual Vision Health, a global leader in virtual reality-based ophthalmic diagnostic and patient engagement technologies, today announced significant company milestones that underscore its continued ...

Post-COVID eye nerve damage leaves millions with corneal nerve loss and pupillary dysfunction that standard exams cannot ...

Government could introduce new eyesight tests for motorists.

D-150 gene therapy enters pivotal Wet-AMD/DME trials, cutting injections up to 89%. Click for this FDMT update.